The S&P 500 and Dow gained while the Nasdaq was little changed at midday, as most sectors aside from technology and communication services rose.
Cintas (CTAS) shares hit an all-time high as the provider of uniforms and services for businesses beat profit and sales estimates and raised its outlook as return-to-office mandates boosted demand.
Also trading at record highs were shares of Merck (MRK) following approval by the Food and Drug Administration (FDA) of its treatment for a rare condition that causes high blood pressure in patients because of restrictions in their lung arteries.
Moderna (MRNA) shares gained as the vaccine maker announced an up to $750 million investment from Blackstone Life Sciences (BX) to develop a flu shot, and said several new vaccines would move to Phase 3 trials.
The rally in shares of Donald Trump’s Trump Media & Technology Group (DJT) continued …